Arkolith/Insider Trading/RVMD/Form 4

Anders Jack

Chief Financial OfficerRevolution Medicines, Inc. (RVMD) · full profile →Form 4 · filed Jun 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.4M
Net Open-Market Flow
-$3.4M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 24, 2026Option exercise(M)20K$18.56$371K143K
Jun 24, 2026Sell(S)5K$167.34$762K139K
Jun 24, 2026Sell(S)9K$168.20$1.6M129K
Jun 24, 2026Sell(S)6K$169.24$956K124K
Jun 24, 2026Sell(S)300$170.32$51K123K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 24, 2026Option exercise(M)20K—$021K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000296) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML